Blood Podcast cover image

Pembrolizumab in PMBCL, allogeneic CD19 CAR T cells for pediatric B-cell ALL, and fetal iron overload in β-thalassemia

Blood Podcast

00:00

The Role of Checkpoint Inhibitors in PMBCL

Long-term follow-up data suggest that some patients may be cured with immune checkpoint blockade alone. The safety profile is reassuring, but larger studies are needed to flesh out the AEE profile. Allogenaic Donor Derived 2nd Generation CD19 CAR T-cells for the treatment of pediatric relapsed refractory BCP-AL.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app